First Trust Exchange Traded Fund Nyse Arca Biotechnology Index Fund Newsroom

Oppenheimer Maintains Incyte(INCY.US) With Buy Rating, Cuts Target Price to $81

Moomoo News08:38 ET

Maintaining Hold on Alkermes: Weighing Solid Performance Against Seasonal Slowdown and Pipeline Uncertainties

TipRanks02:02 ET

JPMorgan Adjusts Price Target on Alkermes to $32 From $31, Maintains Neutral Rating

MT NewswiresJul 25 11:37 ET

HC Wainwright Adjusts Price Target on United Therapeutics to $400 From $300, Maintains Buy Rating

MT NewswiresJul 25 11:04 ET

A Quick Look at Today's Ratings for Alkermes(ALKS.US), With a Forecast Between $32 to $38

Moomoo NewsJul 25 09:24 ET

Alkermes Price Target Raised to $37.00/Share From $35.00 by HC Wainwright & Co.

Dow JonesJul 25 06:57 ET

Alkermes Analyst Ratings

BenzingaJul 25 06:45 ET

H.C. Wainwright Maintains United Therapeutics(UTHR.US) With Buy Rating, Raises Target Price to $400

Moomoo NewsJul 25 06:39 ET

United Therapeutics Analyst Ratings

BenzingaJul 25 06:28 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Alkermes (ALKS) and Viking Therapeutics (VKTX)

TipRanksJul 25 06:25 ET

Strong Performance and Clinical Promise Uphold Buy Rating for Alkermes With $32 Target Price

TipRanksJul 25 00:09 ET

Buy Rating for Alkermes Supported by Strong Q2 Performance and Promising Pipeline Potential

TipRanksJul 24 12:23 ET

Craig-Hallum Maintains Repligen(RGEN.US) With Buy Rating

Moomoo NewsJul 23 09:33 ET

Halozyme Therapeutics Analyst Ratings

BenzingaJul 22 09:35 ET

Exact Sciences (EXAS) Receives a Buy From Piper Sandler

TipRanksJul 19 06:48 ET

Genmab Analyst Ratings

BenzingaJul 18 08:37 ET

TD Cowen Keeps Their Hold Rating on Genmab (GMAB)

TipRanksJul 18 07:39 ET

Wells Fargo Sticks to Its Buy Rating for United Therapeutics (UTHR)

TipRanksJul 18 06:22 ET

Genmab A/S (0MGB) Receives a Buy From Barclays

TipRanksJul 18 02:28 ET

Exact Sciences Analyst Ratings

BenzingaJul 17 12:07 ET